Download PDF

Other users also viewed these articles

Mineralcorticoid receptor blockers in chronic kidney disease Sara Erraez, Manuel López-Mesa, Pablo Gómez-Fernández
10.1016/j.nefroe.2021.08.001
RIPK3 and kidney disease Juan Guerrero-Mauvecin, Miguel Fontecha-Barriuso, Ana M. López-Diaz, Alberto Ortiz, Ana B. Sanz
10.1016/j.nefroe.2023.04.006
Diabetic kidney disease: Is there a non-albuminuric phenotype in type 2 diabetic patients? Ivo Laranjinha, Patrícia Matias, Sofia Mateus, Filipa Aguiar, Patrícia Pereira, Miguel Perneta Santos, Rui Costa, Ana Lourenço, José Guia, José Diogo Barata, Luís Campos
10.1016/j.nefroe.2016.09.003